189 related articles for article (PubMed ID: 10590253)
1. The role of CTLA-4 in tolerance induction and T cell differentiation in experimental autoimmune encephalomyelitis: i.p. antigen administration.
Ratts RB; Arredondo LR; Bittner P; Perrin PJ; Lovett-Racke AE; Racke MK
Int Immunol; 1999 Dec; 11(12):1881-8. PubMed ID: 10590253
[TBL] [Abstract][Full Text] [Related]
2. The role of CTLA-4 in tolerance induction and ttigen administration cell differentiation in experimental autoimmune encephalomyelitis: i. v. antigen administration.
Ratts RB; Arredondo LR; Bittner P; Perrin PJ; Lovett-Racke AE; Racke MK
Int Immunol; 1999 Dec; 11(12):1889-96. PubMed ID: 10590254
[TBL] [Abstract][Full Text] [Related]
3. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.
Eagar TN; Karandikar NJ; Bluestone JA; Miller SD
Eur J Immunol; 2002 Apr; 32(4):972-81. PubMed ID: 11920563
[TBL] [Abstract][Full Text] [Related]
4. CTLA-4: a negative regulator of autoimmune disease.
Karandikar NJ; Vanderlugt CL; Walunas TL; Miller SD; Bluestone JA
J Exp Med; 1996 Aug; 184(2):783-8. PubMed ID: 8760834
[TBL] [Abstract][Full Text] [Related]
5. T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis.
Cross AH; Lyons JA; San M; Keeling RM; Ku G; Racke MK
Eur J Immunol; 1999 Oct; 29(10):3140-7. PubMed ID: 10540325
[TBL] [Abstract][Full Text] [Related]
6. Experimental autoimmune encephalomyelitis in the Wistar rat: dependence of MBP-specific T cell responsiveness on B7 costimulation.
Zhou J; Zhang JS; Ma BL; Mamula MJ
Autoimmunity; 2002 May; 35(3):191-9. PubMed ID: 12389644
[TBL] [Abstract][Full Text] [Related]
7. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
[TBL] [Abstract][Full Text] [Related]
8. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis.
Perrin PJ; Scott D; Quigley L; Albert PS; Feder O; Gray GS; Abe R; June CH; Racke MK
J Immunol; 1995 Feb; 154(3):1481-90. PubMed ID: 7529805
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4 is required for the induction of high dose oral tolerance.
Samoilova EB; Horton JL; Zhang H; Khoury SJ; Weiner HL; Chen Y
Int Immunol; 1998 Apr; 10(4):491-8. PubMed ID: 9620605
[TBL] [Abstract][Full Text] [Related]
10. Acquired thymic tolerance: role of CTLA4 in the initiation and maintenance of tolerance in a clinically relevant autoimmune disease model.
Issazadeh S; Zhang M; Sayegh MH; Khoury SJ
J Immunol; 1999 Jan; 162(2):761-5. PubMed ID: 9916696
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice.
Hurwitz AA; Sullivan TJ; Sobel RA; Allison JP
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3013-7. PubMed ID: 11867713
[TBL] [Abstract][Full Text] [Related]
12. CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis.
Karandikar NJ; Eagar TN; Vanderlugt CL; Bluestone JA; Miller SD
J Neuroimmunol; 2000 Sep; 109(2):173-80. PubMed ID: 10996219
[TBL] [Abstract][Full Text] [Related]
13. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
Zhou T; Weaver C; Linsley PS; Mountz JD
Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
[TBL] [Abstract][Full Text] [Related]
14. Role of interleukin 12 and costimulators in T cell anergy in vivo.
Van Parijs L; Perez VL; Biuckians A; Maki RG; London CA; Abbas AK
J Exp Med; 1997 Oct; 186(7):1119-28. PubMed ID: 9314560
[TBL] [Abstract][Full Text] [Related]
15. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis.
Inobe J; Slavin AJ; Komagata Y; Chen Y; Liu L; Weiner HL
Eur J Immunol; 1998 Sep; 28(9):2780-90. PubMed ID: 9754565
[TBL] [Abstract][Full Text] [Related]
16. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance.
Schwarz A; Beissert S; Grosse-Heitmeyer K; Gunzer M; Bluestone JA; Grabbe S; Schwarz T
J Immunol; 2000 Aug; 165(4):1824-31. PubMed ID: 10925260
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).
Kumar V; Stellrecht K; Sercarz E
J Exp Med; 1996 Nov; 184(5):1609-17. PubMed ID: 8920851
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo.
Metzler B; Burkhart C; Wraith DC
Int Immunol; 1999 May; 11(5):667-75. PubMed ID: 10330272
[TBL] [Abstract][Full Text] [Related]
19. Roles of cytotoxic T-lymphocyte-associated antigen-4 in the inductive phase of oral tolerance.
Chen Y; Ma Y; Chen Y
Immunology; 2002 Feb; 105(2):171-80. PubMed ID: 11872092
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis.
Perrin PJ; Maldonado JH; Davis TA; June CH; Racke MK
J Immunol; 1996 Aug; 157(4):1333-6. PubMed ID: 8759711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]